Insurance Gaps Only Serve to Reinforce Inequality Access to GLP-1 medications is also shaped by the uneven landscape of insurance coverage
Antibody generation has been more often seen with twice-daily exenatide and once-daily lixisenatide, presumably influencing their glycaemic effectiveness
Our semaglutide mixing chart and tirzepatide reconstitution chart simplify the math significantly
PlexusDx complements either approach by offering compounded GLP-1 formulations and a Precision Peptide Genetic Test to help providers personalize dosing and formulation based on metabolic pathway variants
Coryell Health doesnt recommend taking GLP-1 medications if you: Are pregnant or breastfeeding Have a personal or family history of medullary thyroid cancer (MTC) Have a diagnosis of multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal conditions Side effects of taking a GLP-1 medication may include: Loss of appetite Nausea and vomiting Diarrhea Dizziness Mildly increased heart rate Pancreatitis Medullary thyroid cancer (MTC) Acute kidney injury If youre unsure whether an existing condition, your personal history or your family history will not mix well with a GLP-1 medication, talk with your Coryell Health primary care provider to determine whether a GLP-1 medication is right for you
It's worth noting that in the UK, Ozempic is licensed specifically for the treatment of type 2 diabetes, while Wegovy (also semaglutide, but at different doses) is licensed for weight management
